Alexion Pharmaceuticals investor relations material

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for patients with rare and severe disorders. Alexion’s core business is focused on serving individuals afflicted with ultra-rare disorders through commercializing high-quality products that are priced based on their value. Alexion Pharmaceuticals is a subsidiary of AstraZeneca, and an American pharmaceutical company headquartered in Boston, Massachusetts